Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702025 · ClinicalTrials.gov registry record · Phase 1
Rapid Acclimatization to Hypoxia at Altitude
A Phase 1 study of Physiological Function in Low Oxygen Environment, sponsored by Colorado State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT01702025 is a Phase 1 study of Physiological Function in Low Oxygen Environment that has completed, run by Colorado State University. The registered enrollment target is 41 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01702025, a Phase 1 study of Physiological Function in Low Oxygen Environment, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Methazolamide
- DRUG Aminophylline
- DRUG Aminophylline+Methazolamide
Study Locations (1)
Colorado
- Colorado State University, Dept. of Health and Exercise Science - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702025
The ClinicalTrials.gov registry entry for NCT01702025 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Physiological Function in Low Oxygen Environment appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT01702025 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01702025 about?
NCT01702025 is a clinical study titled "Rapid Acclimatization to Hypoxia at Altitude". In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study t...
What is the current status of trial NCT01702025?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2012-06. Estimated completion is 2012-12.
What conditions does trial NCT01702025 study?
This clinical trial studies the following conditions: Physiological Function in Low Oxygen Environment.
What interventions are being tested in trial NCT01702025?
The interventions under investigation include: Placebo (DRUG), Methazolamide (DRUG), Aminophylline (DRUG), Aminophylline+Methazolamide (DRUG).
Who is sponsoring clinical trial NCT01702025?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01702025 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.